Kathleen E. Malone

20.7k total citations · 2 hit papers
221 papers, 12.3k citations indexed

About

Kathleen E. Malone is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Kathleen E. Malone has authored 221 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 99 papers in Genetics and 74 papers in Cancer Research. Recurrent topics in Kathleen E. Malone's work include Cancer Risks and Factors (124 papers), BRCA gene mutations in cancer (56 papers) and Breast Cancer Treatment Studies (49 papers). Kathleen E. Malone is often cited by papers focused on Cancer Risks and Factors (124 papers), BRCA gene mutations in cancer (56 papers) and Breast Cancer Treatment Studies (49 papers). Kathleen E. Malone collaborates with scholars based in United States, Denmark and South Africa. Kathleen E. Malone's co-authors include Janet R. Daling, Christopher I. Li, Peggy L. Porter, Leslie Bernstein, David R. Doody, Elaine A. Ostrander, Polly A. Marchbanks, Noel S. Weiss, Michael S. Simon and Louise A. Brinton and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Kathleen E. Malone

219 papers receiving 11.9k citations

Hit Papers

Expression of cell-cycle regulators p27Kip1 and cyclin E,... 1997 2026 2006 2016 1997 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
    1997 791 citations Peggy L. Porter, Kathleen E. Malone et al. profile →
  2. Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity
    2003 557 citations Christopher I. Li, Kathleen E. Malone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen E. Malone United States 63 7.2k 4.0k 3.9k 2.7k 1.7k 221 12.3k
Victor G. Vogel United States 49 8.0k 1.1× 5.5k 1.4× 6.7k 1.7× 2.4k 0.9× 1.1k 0.6× 173 16.1k
Timothy R. Rebbeck United States 56 3.7k 0.5× 2.7k 0.7× 5.6k 1.4× 3.0k 1.1× 1.2k 0.7× 257 12.7k
Pamela J. Goodwin Canada 61 6.9k 1.0× 2.7k 0.7× 1.6k 0.4× 4.9k 1.8× 1.2k 0.7× 172 12.2k
Claudine Isaacs United States 63 4.8k 0.7× 3.7k 0.9× 7.9k 2.0× 2.7k 1.0× 1.4k 0.8× 279 13.8k
Giske Ursin United States 58 6.2k 0.9× 2.4k 0.6× 2.6k 0.7× 1.2k 0.4× 2.0k 1.2× 296 11.1k
Steinar Tretli Norway 64 4.8k 0.7× 2.1k 0.5× 1.3k 0.3× 2.6k 1.0× 1.5k 0.9× 243 11.4k
Christopher I. Li United States 55 5.9k 0.8× 3.8k 0.9× 2.1k 0.5× 1.8k 0.7× 745 0.4× 196 10.2k
Ping Sun Canada 47 4.9k 0.7× 4.4k 1.1× 4.2k 1.1× 2.8k 1.1× 716 0.4× 128 10.9k
Patricia G. Moorman United States 41 4.8k 0.7× 3.3k 0.8× 2.0k 0.5× 1.7k 0.6× 1.1k 0.6× 135 8.7k
Montserrat García‐Closas United States 55 3.2k 0.4× 2.8k 0.7× 3.4k 0.9× 4.9k 1.8× 938 0.5× 205 11.2k

Countries citing papers authored by Kathleen E. Malone

Since Specialization
Citations

This map shows the geographic impact of Kathleen E. Malone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen E. Malone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen E. Malone more than expected).

Fields of papers citing papers by Kathleen E. Malone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen E. Malone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen E. Malone. The network helps show where Kathleen E. Malone may publish in the future.

Co-authorship network of co-authors of Kathleen E. Malone

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen E. Malone. A scholar is included among the top collaborators of Kathleen E. Malone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen E. Malone. Kathleen E. Malone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watt, Gordon P., Anne S. Reiner, Xiang Shu, et al.. (2025). Polygenic risk of coronary artery disease for long-term survivors of breast cancer. JNCI Journal of the National Cancer Institute. 117(10). 2073–2081. 1 indexed citations
2.
Malone, Kathleen E., et al.. (2024). Statin use and risks of breast cancer recurrence and mortality. Cancer. 130(18). 3106–3114. 4 indexed citations
3.
Reiner, Anne S., Julia A. Knight, Esther M. John, et al.. (2024). Agreement of medical record abstraction and self‐report of breast cancer treatment with an extended recall window. Cancer. 131(1). e35459–e35459.
4.
Othus, Megan, et al.. (2023). Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 33(2). 288–297. 3 indexed citations
5.
Li, Christopher I., Meghan R. Flanagan, Mei‐Tzu C. Tang, Peggy L. Porter, & Kathleen E. Malone. (2021). Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma In Situ. Cancer Research. 81(10). 2799–2802. 2 indexed citations
6.
Malone, Kathleen E., et al.. (2021). Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis. Breast Cancer Research and Treatment. 190(3). 549–558. 14 indexed citations
7.
Sisti, Julia, Jonine L. Bernstein, Charles F. Lynch, et al.. (2015). Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. SpringerPlus. 4(1). 825–825. 17 indexed citations
8.
Beaber, Elisabeth F., Kathleen E. Malone, Mei-Tzu C. Tang, et al.. (2014). Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women. Cancer Epidemiology Biomarkers & Prevention. 23(5). 755–764. 53 indexed citations
9.
Ma, Huiyan, Yani Lu, Kathleen E. Malone, et al.. (2013). Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer. 13(1). 225–225. 47 indexed citations
10.
Huang, Yi, Kathleen E. Malone, Kara L. Cushing‐Haugen, Janet R. Daling, & Christopher I. Li. (2011). Relationship between Menopausal Symptoms and Risk of Postmenopausal Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 20(2). 379–388. 19 indexed citations
11.
Berstad, Paula, Ralph J. Coates, Leslie Bernstein, et al.. (2010). A Case-Control Study of Body Mass Index and Breast Cancer Risk in White and African-American Women. Cancer Epidemiology Biomarkers & Prevention. 19(6). 1532–1544. 86 indexed citations
12.
Phipps, Amanda I., Diana S.M. Buist, Kathleen E. Malone, et al.. (2010). Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Research and Treatment. 126(3). 671–678. 38 indexed citations
13.
Daling, Janet R., Emily White, Louise A. Brinton, et al.. (2009). Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years. Cancer Epidemiology Biomarkers & Prevention. 18(4). 1157–1166. 196 indexed citations
14.
Loo, Lenora W. M., Carl C.T. Ton, Douglas I. Grove, et al.. (2006). Identification of genomic alterations differentiating lobular and ductal subtypes of breast cancer. Cancer Research. 66. 611–612. 2 indexed citations
15.
Li, Christopher I., et al.. (2005). Antidepressant use and breast cancer risk. Cancer Research. 65. 758–758. 1 indexed citations
16.
Loo, Lenora W. M., Douglas I. Grove, Eleanor Williams, et al.. (2004). Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes. Cancer Research. 64(23). 8541–8549. 173 indexed citations
17.
Boudreau, Denise M., Jacqueline S. Gardner, Kathleen E. Malone, et al.. (2004). The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women. Cancer. 100(11). 2308–2316. 99 indexed citations
18.
Weiss, Linda K., Ronald T. Burkman, Kara L. Cushing‐Haugen, et al.. (2002). Hormone Replacement Therapy Regimens and Breast Cancer Risk. Obstetrics and Gynecology. 100(6). 1148–1158. 1 indexed citations
19.
Madigan, M. Patricia, Rebecca Troisi, Nancy Potischman, et al.. (2000). Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women. International Journal of Epidemiology. 29(5). 793–798. 57 indexed citations
20.
Brinton, Louise A., Marilie D. Gammon, Kathleen E. Malone, et al.. (1997). Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women. Contraception. 55(4). 197–203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor G. Vogel Breakdown of academic impact, for papers by Timothy R. Rebbeck Breakdown of academic impact, for papers by Pamela J. Goodwin Breakdown of academic impact, for papers by Claudine Isaacs Breakdown of academic impact, for papers by Giske Ursin Breakdown of academic impact, for papers by Steinar Tretli Breakdown of academic impact, for papers by Christopher I. Li Breakdown of academic impact, for papers by Ping Sun Breakdown of academic impact, for papers by Patricia G. Moorman Breakdown of academic impact, for papers by Montserrat García‐Closas
Rankless by CCL
2026